Global ICU-acquired Acute Kidney Treatment Market Insights and Forecast to 2028

SKU ID : QYR-20149717 | Publishing Date : 09-Feb-2022 | No. of pages : 94

Detailed TOC of Global ICU-acquired Acute Kidney Treatment Market Insights and Forecast to 2028

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Pre-renal
        1.2.3 Intrinsic-renal
        1.2.4 Post-renal
    1.3 Market by Application
        1.3.1 Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Public Hospital
        1.3.3 Private Hospital
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global ICU-acquired Acute Kidney Treatment Market Perspective (2017-2028)
    2.2 ICU-acquired Acute Kidney Treatment Growth Trends by Region
        2.2.1 ICU-acquired Acute Kidney Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 ICU-acquired Acute Kidney Treatment Historic Market Size by Region (2017-2022)
        2.2.3 ICU-acquired Acute Kidney Treatment Forecasted Market Size by Region (2023-2028)
    2.3 ICU-acquired Acute Kidney Treatment Market Dynamics
        2.3.1 ICU-acquired Acute Kidney Treatment Industry Trends
        2.3.2 ICU-acquired Acute Kidney Treatment Market Drivers
        2.3.3 ICU-acquired Acute Kidney Treatment Market Challenges
        2.3.4 ICU-acquired Acute Kidney Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue
        3.1.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue (2017-2022)
        3.1.2 Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global ICU-acquired Acute Kidney Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by ICU-acquired Acute Kidney Treatment Revenue
    3.4 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio
        3.4.1 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by ICU-acquired Acute Kidney Treatment Revenue in 2021
    3.5 ICU-acquired Acute Kidney Treatment Key Players Head office and Area Served
    3.6 Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service
    3.7 Date of Enter into ICU-acquired Acute Kidney Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 ICU-acquired Acute Kidney Treatment Breakdown Data by Type
    4.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Type (2017-2022)
    4.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2023-2028)
5 ICU-acquired Acute Kidney Treatment Breakdown Data by Application
    5.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Application (2017-2022)
    5.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America ICU-acquired Acute Kidney Treatment Market Size (2017-2028)
    6.2 North America ICU-acquired Acute Kidney Treatment Market Size by Type
        6.2.1 North America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022)
        6.2.2 North America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028)
        6.2.3 North America ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028)
    6.3 North America ICU-acquired Acute Kidney Treatment Market Size by Application
        6.3.1 North America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022)
        6.3.2 North America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028)
        6.3.3 North America ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028)
    6.4 North America ICU-acquired Acute Kidney Treatment Market Size by Country
        6.4.1 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022)
        6.4.2 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe ICU-acquired Acute Kidney Treatment Market Size (2017-2028)
    7.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Type
        7.2.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022)
        7.2.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028)
        7.2.3 Europe ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028)
    7.3 Europe ICU-acquired Acute Kidney Treatment Market Size by Application
        7.3.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022)
        7.3.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028)
        7.3.3 Europe ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028)
    7.4 Europe ICU-acquired Acute Kidney Treatment Market Size by Country
        7.4.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022)
        7.4.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size (2017-2028)
    8.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type
        8.2.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application
        8.3.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region
        8.4.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia
9 Latin America
    9.1 Latin America ICU-acquired Acute Kidney Treatment Market Size (2017-2028)
    9.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type
        9.2.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028)
    9.3 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application
        9.3.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028)
    9.4 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country
        9.4.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size (2017-2028)
    10.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type
        10.2.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application
        10.3.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country
        10.4.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Quark Pharmaceuticals
        11.1.1 Quark Pharmaceuticals Company Details
        11.1.2 Quark Pharmaceuticals Business Overview
        11.1.3 Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Introduction
        11.1.4 Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022)
        11.1.5 Quark Pharmaceuticals Recent Developments
    11.2 Fresenius Medical Care
        11.2.1 Fresenius Medical Care Company Details
        11.2.2 Fresenius Medical Care Business Overview
        11.2.3 Fresenius Medical Care ICU-acquired Acute Kidney Treatment Introduction
        11.2.4 Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022)
        11.2.5 Fresenius Medical Care Recent Developments
    11.3 B. Braun
        11.3.1 B. Braun Company Details
        11.3.2 B. Braun Business Overview
        11.3.3 B. Braun ICU-acquired Acute Kidney Treatment Introduction
        11.3.4 B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022)
        11.3.5 B. Braun Recent Developments
    11.4 Baxter international
        11.4.1 Baxter international Company Details
        11.4.2 Baxter international Business Overview
        11.4.3 Baxter international ICU-acquired Acute Kidney Treatment Introduction
        11.4.4 Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022)
        11.4.5 Baxter international Recent Developments
    11.5 Angion Biomedica Corp
        11.5.1 Angion Biomedica Corp Company Details
        11.5.2 Angion Biomedica Corp Business Overview
        11.5.3 Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Introduction
        11.5.4 Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022)
        11.5.5 Angion Biomedica Corp Recent Developments
    11.6 Asahi Kasei Medical
        11.6.1 Asahi Kasei Medical Company Details
        11.6.2 Asahi Kasei Medical Business Overview
        11.6.3 Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Introduction
        11.6.4 Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022)
        11.6.5 Asahi Kasei Medical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Figures, Tables and Charts Available in Global ICU-acquired Acute Kidney Treatment Market Insights and Forecast to 2028

List of Tables
    Table 1. Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Pre-renal
    Table 3. Key Players of Intrinsic-renal
    Table 4. Key Players of Post-renal
    Table 5. Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global ICU-acquired Acute Kidney Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global ICU-acquired Acute Kidney Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global ICU-acquired Acute Kidney Treatment Market Share by Region (2017-2022)
    Table 9. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global ICU-acquired Acute Kidney Treatment Market Share by Region (2023-2028)
    Table 11. ICU-acquired Acute Kidney Treatment Market Trends
    Table 12. ICU-acquired Acute Kidney Treatment Market Drivers
    Table 13. ICU-acquired Acute Kidney Treatment Market Challenges
    Table 14. ICU-acquired Acute Kidney Treatment Market Restraints
    Table 15. Global ICU-acquired Acute Kidney Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global ICU-acquired Acute Kidney Treatment Revenue Share by Players (2017-2022)
    Table 17. Global Top ICU-acquired Acute Kidney Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2021)
    Table 18. Ranking of Global Top ICU-acquired Acute Kidney Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by ICU-acquired Acute Kidney Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service
    Table 22. Date of Enter into ICU-acquired Acute Kidney Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global ICU-acquired Acute Kidney Treatment Revenue Share by Application (2017-2022)
    Table 30. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global ICU-acquired Acute Kidney Treatment Revenue Share by Application (2023-2028)
    Table 32. North America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Quark Pharmaceuticals Company Details
    Table 63. Quark Pharmaceuticals Business Overview
    Table 64. Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Product
    Table 65. Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million)
    Table 66. Quark Pharmaceuticals Recent Developments
    Table 67. Fresenius Medical Care Company Details
    Table 68. Fresenius Medical Care Business Overview
    Table 69. Fresenius Medical Care ICU-acquired Acute Kidney Treatment Product
    Table 70. Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million)
    Table 71. Fresenius Medical Care Recent Developments
    Table 72. B. Braun Company Details
    Table 73. B. Braun Business Overview
    Table 74. B. Braun ICU-acquired Acute Kidney Treatment Product
    Table 75. B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million)
    Table 76. B. Braun Recent Developments
    Table 77. Baxter international Company Details
    Table 78. Baxter international Business Overview
    Table 79. Baxter international ICU-acquired Acute Kidney Treatment Product
    Table 80. Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million)
    Table 81. Baxter international Recent Developments
    Table 82. Angion Biomedica Corp Company Details
    Table 83. Angion Biomedica Corp Business Overview
    Table 84. Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Product
    Table 85. Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million)
    Table 86. Angion Biomedica Corp Recent Developments
    Table 87. Asahi Kasei Medical Company Details
    Table 88. Asahi Kasei Medical Business Overview
    Table 89. Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Product
    Table 90. Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million)
    Table 91. Asahi Kasei Medical Recent Developments
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global ICU-acquired Acute Kidney Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Pre-renal Features
    Figure 3. Intrinsic-renal Features
    Figure 4. Post-renal Features
    Figure 5. Global ICU-acquired Acute Kidney Treatment Market Share by Application: 2021 VS 2028
    Figure 6. Public Hospital Case Studies
    Figure 7. Private Hospital Case Studies
    Figure 8. ICU-acquired Acute Kidney Treatment Report Years Considered
    Figure 9. Global ICU-acquired Acute Kidney Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global ICU-acquired Acute Kidney Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global ICU-acquired Acute Kidney Treatment Market Share by Region: 2021 VS 2028
    Figure 12. Global ICU-acquired Acute Kidney Treatment Market Share by Players in 2021
    Figure 13. Global Top ICU-acquired Acute Kidney Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by ICU-acquired Acute Kidney Treatment Revenue in 2021
    Figure 15. North America ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028)
    Figure 17. North America ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028)
    Figure 18. North America ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028)
    Figure 19. United States ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028)
    Figure 23. Europe ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028)
    Figure 24. Europe ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028)
    Figure 25. Germany ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size Share by Region (2017-2028)
    Figure 35. China ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028)
    Figure 45. Mexico ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028)
    Figure 51. Turkey ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Quark Pharmaceuticals Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022)
    Figure 55. Fresenius Medical Care Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022)
    Figure 56. B. Braun Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022)
    Figure 57. Baxter international Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022)
    Figure 58. Angion Biomedica Corp Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022)
    Figure 59. Asahi Kasei Medical Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed

Keyplayers in Global ICU-acquired Acute Kidney Treatment Market Insights and Forecast to 2028

Quark Pharmaceuticals
Fresenius Medical Care
B. Braun
Baxter international
Angion Biomedica Corp
Asahi Kasei Medical

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]